Cargando…

Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [(18)F]F-FDG in Oncology: A Systematic Review

Several recent studies comparing radiolabeled fibroblast activation protein inhibitors (FAPI) and fluorine-18 fluorodeoxyglucose ([(18)F]F-FDG) as positron emission tomography (PET) radiotracers in oncology have been published. The aim of this systematic review is to perform an updated evidence-base...

Descripción completa

Detalles Bibliográficos
Autores principales:	Treglia, Giorgio, Muoio, Barbara, Roustaei, Hessamoddin, Kiamanesh, Zahra, Aryana, Kamran, Sadeghi, Ramin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537105/ https://www.ncbi.nlm.nih.gov/pubmed/34681850 http://dx.doi.org/10.3390/ijms222011192

Ejemplares similares

Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?
por: Roustaei, Hessamoddin, et al.
Publicado: (2022)

Head-to-head comparison of (18)F-FAPI and (18)F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma
por: Zhang, Jing, et al.
Publicado: (2023)

Prevalence and malignancy risk of focal colorectal incidental uptake detected by (18)F-FDG-PET or PET/CT: a meta-analysis
por: Treglia, Giorgio, et al.
Publicado: (2014)

Head-to-Head Comparison of [(68) Ga]Ga-FAPI-46-PET/CT and [(18)F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer
por: Wegen, Simone, et al.
Publicado: (2022)

Head-to-head Intra-individual Comparison of [(68)Ga]-FAPI and [(18)F]-FDG PET/CT in Patients with Bladder Cancer
por: Novruzov, E., et al.
Publicado: (2022)

Head-to-Head Comparison between [(68)Ga]Ga-DOTA.SA.FAPi and [(18)F]F-FDG PET/CT Imaging in Patients with Breast Cancer
por: Ballal, Sanjana, et al.
Publicado: (2023)

Head-to-Head Intra-Individual Comparison of Biodistribution and Tumor Uptake of [(18)F]FAPI-74 with [(18)F]FDG in Patients with PDAC: A Prospective Exploratory Study
por: Novruzov, Emil, et al.
Publicado: (2023)

Head-to-head intra-individual comparison of biodistribution and tumor uptake of (68)Ga-FAPI and (18)F-FDG PET/CT in cancer patients
por: Giesel, Frederik L., et al.
Publicado: (2021)

Head-to-head comparison of [(68)Ga]Ga-FAPI-04 and [(18)F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma
por: Kuten, Jonathan, et al.
Publicado: (2021)

Head-to-head evaluation of [(18)F]FDG and [(68) Ga]Ga-DOTA-FAPI-04 PET/CT in recurrent soft tissue sarcoma
por: Gu, Bingxin, et al.
Publicado: (2022)

Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature
por: Guglielmo, Priscilla, et al.
Publicado: (2023)

[(68)Ga] Ga-Pentixafor diffuse bilateral Adrenal & Breast uptake in a patient with High-grade Glioma: A note of caution on normal variants
por: Roustaei, Hessamoddin, et al.
Publicado: (2023)

Head-to-Head Comparison between (18)F-FES PET/CT and (18)F-FDG PET/CT in Oestrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-Analysis
por: Piccardo, Arnoldo, et al.
Publicado: (2022)

Solitary Plasmacytoma of the Sternum Mimicking Bone Metastasis in a Patient with a History of Breast Cancer Evaluated by F-18-FDG PET/CT
por: Treglia, Giorgio, et al.
Publicado: (2013)

(18)F-FDG PET Imaging in the Evaluation of Treatment Response to New Chemotherapies beyond Imatinib for Patients with Gastrointestinal Stromal Tumors
por: Stefanelli, Antonella, et al.
Publicado: (2011)

The Added Value of (68)Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with (18)F-FDG–Negative Findings
por: Gu, Bingxin, et al.
Publicado: (2022)

Head-to-head comparison of (68)Ga-FAPI-04 PET/CT and (18)F-FDG PET/CT in the evaluation of primary digestive system cancer: a systematic review and meta-analysis
por: Ouyang, Jiqi, et al.
Publicado: (2023)

Novel Radiotracers for Molecular Imaging of Myocardial Inflammation: an Update Focused on Clinical Translation of Non-18F-FDG Radiotracers
por: Shi, Tiantian, et al.
Publicado: (2023)

Activated fibroblasts in muscle sarcoidosis revealed by [(18)F]FAPI-74 PET
por: Watabe, Tadashi, et al.
Publicado: (2023)

Prevalence and Significance of Hypermetabolic Lymph Nodes Detected by 2-[(18)F]FDG PET/CT after COVID-19 Vaccination: A Systematic Review and a Meta-Analysis
por: Treglia, Giorgio, et al.
Publicado: (2021)

A Case with (68)Ga-FAPI Positive and (18)F-FDG Negative Breast Cancer
por: Kömek, Halil, et al.
Publicado: (2021)

Comparison of (18)F-FDG PET/CT and (68)Ga-FAPI in Spindle Cell Rhabdomyosarcoma
por: Shen, Zhihui, et al.
Publicado: (2023)

A dataset of [(68)Ga]Ga-Pentixafor PET/CT images of patients with high-grade Glioma
por: Roustaei, Hessamoddin, et al.
Publicado: (2023)

The role of (18)F-FDG PET for COVID-19 infection: myth versus reality
por: Treglia, Giorgio
Publicado: (2020)

Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [(18)F]F-FDG PET/CT in Patients with Liver Malignancies
por: Siripongsatian, Dheeratama, et al.
Publicado: (2022)

(68)Ga-FAPI-04 Versus (18)F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
por: Wang, Hao, et al.
Publicado: (2021)

Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG Uptake in Esophageal Cancer
por: Liu, Huipan, et al.
Publicado: (2022)

FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances
por: Veldhuijzen van Zanten, Sophie E. M., et al.
Publicado: (2022)

A case of [(68)Ga]Ga-FAPI-46-avid and [(18)F]F-FDG-negative COVID-19 pneumonia sequelae
por: Telo, Silvi, et al.
Publicado: (2022)

Diagnostic value of [(68)Ga]Ga-FAPI-04 in patients with colorectal cancer in comparison with [(18)F]F-FDG PET/CT
por: Lin, Xinfeng, et al.
Publicado: (2023)

Diagnostic Performance of (18)F-FDG PET or PET/CT for Detection of Post-Transplant Lymphoproliferative Disorder: A Systematic Review and a Bivariate Meta-Analysis
por: Ballova, Veronika, et al.
Publicado: (2020)

Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers
por: Syed, M., et al.
Publicado: (2020)

[(18)F] AlF‑NOTA‑FAPI‑04 PET/CT as a promising tool for imaging fibroblast activation protein in gastrointestinal system cancers: a prospective investigation of comparative analysis with (18)F-FDG
por: Yang, Liping, et al.
Publicado: (2023)

Diagnostic Performance of (18)F-FDG PET/CT in Infectious and Inflammatory Diseases according to Published Meta-Analyses
por: Treglia, Giorgio
Publicado: (2019)

Clinical application of Al(18)F-NOTA-FAPI PET/CT in diagnosis and TNM staging of pancreatic adenocarcinoma, compared to (18)F-FDG
por: Lyu, Zhehao, et al.
Publicado: (2023)

Neuro-Oncology and Positron Emission Tomography: “Just Can’t Get Enough”
por: Muoio, Barbara, et al.
Publicado: (2023)

Diagnostic Performance of PET or PET/CT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours according to Published Meta-Analyses
por: Lococo, Filippo, et al.
Publicado: (2020)

Predicting Future Morphological Changes of Lesions from Radiotracer Uptake in 18F-FDG-PET Images
por: Bagci, Ulas, et al.
Publicado: (2013)

Preclinical evaluation and pilot clinical study of [(18)F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts
por: Hu, Kongzhen, et al.
Publicado: (2022)

Imaging of atherosclerosis with [(64)Cu]Cu-DOTA-TATE in a translational head-to-head comparison study with [(18)F]FDG, and Na[(18)F]F in rabbits
por: Grandjean, Constance E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_is2kseggcgqhk0ncvp9d7jd5bl